Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

Ohio to end GLP-1 drug coverage for most state workers without diabetes, citing soaring Medicaid costs and rising demand for ...

The singer explained she prefers to call her weight loss journey a process of 'weight release', admitting she tried GLP-1 ...

Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes CHICAGO, June 22, 2025 ...

The influencer is still pushing brands to make bigger sizes and is publishing a new novel with a plus-size heroine. She is ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to-moderate and other outcome results, ...

The ‘About Damn Time’ hitmaker, once a body positivity icon, faces Ozempic rumours. Fans feel conflicted and wonder if Lizzo ...